This trial looks at how well active monitoring works for patients with low-risk germ cell tumors after surgery. It also compares two chemotherapy drugs, carboplatin and cisplatin, for patients with standard-risk germ cell tumors. The goal is to understand which treatment is better for patients and to explore the effects of chemotherapy on their health.
The trial's ID number is NCT03067181. It is a Phase 3 study, meaning it is looking at how well the treatments work and how safe they are. This trial is FDA-regulated and aims to include about 1,780 participants.
Who can join
This study includes both children and adults. It is open to patients with newly diagnosed germ cell tumors. There are specific age requirements for different groups. Patients must meet certain medical criteria to join. The trial team will confirm if you are eligible to participate.
Conditions
Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor, Malignant Ovarian Teratoma, Stage I Ovarian Choriocarcinoma, Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage I Testicular Choriocarcinoma AJCC v6 and v7, Stage I Testicular Embryonal Carcinoma AJCC v6 and v7, Stage I Testicular Seminoma AJCC v6 and v7, Stage I Testicular Yolk Sac Tumor AJCC v6 and v7, Stage II Ovarian Choriocarcinoma, Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage II Testicular Choriocarcinoma AJCC v6 and v7, Stage II Testicular Embryonal Carcinoma AJCC v6 and v7, Stage II Testicular Yolk Sac Tumor AJCC v6 and v7, Stage III Ovarian Choriocarcinoma, Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage III Testicular Choriocarcinoma AJCC v6 and v7, Stage III Testicular Embryonal Carcinoma AJCC v6 and v7, Stage III Testicular Yolk Sac Tumor AJCC v6 and v7, Stage IV Ovarian Choriocarcinoma, Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7, Testicular Mixed Choriocarcinoma and Embryonal Carcinoma, Testicular Mixed Choriocarcinoma and Teratoma, Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
Age group
All ages
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be placed into different treatment groups by chance. Some will receive carboplatin or cisplatin with other medicines. Others will be monitored without immediate treatment. Everyone will have tests like CT scans, MRIs, and blood tests throughout the trial. Some may also have a biopsy.
Where
This trial is enrolling at 566 locations. Recruiting sites are listed first.
Treats cervical cancer, uterine cancer, ovarian cancer and vulvar cancer. Offers laparoscopic surgery, fertility-sparing surgery and prophylactic surgery.
Chief of gynecologic medical oncology, MSK. Treats cervical cancer, uterine cancer and ovarian cancer. Offers chemotherapy. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.